Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol + ketamine versus haloperidol + pethidine versus placebo for prevention of catheter-related bladder discomfort after lumbar laminectomy
IRCT20171012036730N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cystitis comparing Haloperidol + ketamine, Haloperidol + pethidine and Placebo (3 arms). Primary endpoints: Bladder discomfort, Pain and 1 more. Started Sep 2016; status: completed.
02
Drugs
haloperidolketaminepethidine
03
Conditions
cystitis
Beyond the preview
Go deeper on IRCT20171012036730N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171012036730N2.